Showing results (491-500 of 516) with videos related to
Sort By:
Pageof 52
Annals of the Rheumatic Diseases|March 18, 2016
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiativeAthan Baillet, Laure Gossec, Loreto Carmona, et al.Emerging Infectious Diseases|October 22, 2015
Contact Tracing Activities during the Ebola Virus Disease Epidemic in Kindia and Faranah, Guinea, 2014Meredith G Dixon, Melanie M Taylor, Jacob Dee, et al.Annals of the Rheumatic Diseases|March 3, 2016
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forceCindy Strehl, Johannes W J Bijlsma, Maarten de Wit, et al.International Journal of Radiation Oncology, Biology, Physics|September 24, 2017
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled TrialThomas M Churilla, Karla V Ballman, Paul D Brown, et al.Journal of the National Cancer Institute|August 25, 2020
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT DatabaseAnna D Wagner, Axel Grothey, Thierry Andre, et al.The American Journal of Pathology|March 11, 2021
The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular MeshworkChenna Kesavulu Sugali, Naga Pradeep Rayana, Jiannong Dai, et al.Emerging Infectious Diseases|January 6, 2026
Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020Ekaterina V Kurbatova, William C Whitworth, Kia E Bryant, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2025
Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized TrialsQian Shi, Bruno Paiva, Levi D Pederson, et al.Neuro-Oncology|July 18, 2020
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study designKurt A Jaeckle, Karla V Ballman, Martin van den Bent, et al.JAMA Oncology|October 31, 2024
Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical TrialJann N Sarkaria, Karla V Ballman, Sani H Kizilbash, et al.Pageof 52